Current treatment of in-stent restenosis

Journal of the American College of Cardiology

Volumn 63, Issue 24, 2014, Pages 2659-2673

  Alfonso, Fernando ^a   Byrne, Robert A ^b,c   Rivero, Fernando ^a   Kastrati, Adnan ^b,c  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

bare metal stents; drug coated balloons; drug eluting stents; in stent restenosis; intravascular ultrasound; neoatherosclerosis; optical coherence tomography

Indexed keywords

ABCIXIMAB; EVEROLIMUS; PACLITAXEL; RAPAMYCIN;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BALLOON DILATATION; BARE METAL STENT; BIORESORBABLE SCAFFOLD; BIORESORBABLE VASCULAR SCAFFOLD; BRACHYTHERAPY; CUTTING BALLOON ANGIOPLASTY; DRUG COATED BALLOON; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEAT PROCEDURE; REVIEW; ROTATIONAL ATHERECTOMY; SCORING BALLOON ANGIOPLASTY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SYSTEMATIC REVIEW; THORAX PAIN; UNSPECIFIED SIDE EFFECT; ADULT; AGED; ARTICLE; ATHERECTOMY; BALLOON; CUTTING BALLOON; MAJOR CLINICAL STUDY; MIDDLE AGED; PATIENT CARE; SCORING BALLOON;

BARE-METAL STENTS; DRUG-COATED BALLOONS; DRUG-ELUTING STENTS; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; NEOATHEROSCLEROSIS; OPTICAL COHERENCE TOMOGRAPHY;

ANIMALS; CLINICAL TRIALS AS TOPIC; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84902602889     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.02.545     Document Type: Review

References (104)

1. F. Alfonso Treatment of drug-eluting stent restenosis the new pilgrimage: quo vadis? J Am Coll Cardiol 55 2010 2717 2720
2. B. García Del Blanco, J.R. Rumoroso Cuevas, F. Hernández Hernández, and R. Trillo Nouche Spanish Cardiac Catheterization and Coronary Intervention Registry. 22nd official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2012) Rev Esp Cardiol 66 2013 894 904
3. G.G. Stefanini, and D.R. Holmes Jr. Drug-eluting coronary-artery stents N Engl J Med 368 2013 254 265
4. C. Stettler, S. Wandel, and S. Allemann et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
5. R.A. Byrne, N. Sarafoff, A. Kastrati, and A. Schomig Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment Drug Saf 32 2009 749 770
6. A. Kastrati, J. Mehilli, and J. Pache et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
7. S. Cassese, R.A. Byrne, and T. Tada et al. Incidence and predictors of restenosis after coronary stenting in 10,004 patients with surveillance angiography Heart 100 2014 153 159
8. T. Tada, R.A. Byrne, and I. Simunovic et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients J Am Coll Cardiol Intv 6 2013 1267 1274
9. F. Alfonso, and C. Fernandez Second-generation drug-eluting stents. Moving the field forward J Am Coll Cardiol 58 2011 26 29
10. R.A. Byrne, S. Cassese, and T. Windisch et al. Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials EuroIntervention 9 2013 797 802
11. P.S. Teirstein, V. Massullo, and S. Jani et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting N Engl J Med 336 1997 1697 1703
12. R. Waksman, R.L. White, and R.C. Chan et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis Circulation 101 2000 2165 2171
13. M.B. Leon, P.S. Teirstein, and J.W. Moses Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting N Engl J Med 344 2001 250 256
14. J. vom Dahl, U. Dietz, and P.K. Haager et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the Angioplasty Versus Rotational Atherectomy for Treatment of Diffuse In-stent Restenosis Trial (ARTIST) Circulation 105 2002 583 588
15. F. Alfonso, J. Zueco, and A. Cequier et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis J Am Coll Cardiol 42 2003 796 805
16. R. Waksman, E. Cheneau, and A.E. Ajani et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) studies Circulation 107 2003 1744 1749
17. J. Hausleiter, A. Kastrati, and J. Mehilli et al. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial Circulation 110 2004 790 795
18. M. Ragosta, H. Samady, and L.W. Gimple et al. Percutaneous treatment of focal vs. diffuse in-stent restenosis: a prospective randomized comparison of conventional therapies Catheter Cardiovasc Interv 61 2004 344 349
19. P. Montorsi, S. Galli, F. Fabbiocchi, D. Trabattoni, P.M. Ravagnani, and A.L. Bartorelli Randomized trial of conventional balloon angioplasty versus cutting balloon for in-stent restenosis. Acute and 24-hour angiographic and intravascular ultrasound changes and long-term follow-up Ital Heart J 5 2004 271 279
20. R. Albiero, S. Silber, and C. Di Mario et al. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the Restenosis Cutting Balloon Evaluation Trial (RESCUT) J Am Coll Cardiol 43 2004 943 949
21. S.K. Sharma, A. Kini, and R. Mehran et al. Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-stent Restenosis (ROSTER) Am Heart J 147 2004 16 22
22. A. Kastrati, J. Mehilli, and N. von Beckerath et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
23. F. Alfonso, P. García, and H. Fleites et al. Repeat stenting for the prevention of the early lumen loss phenomenon in patients with in-stent restenosis. Angiographic and intravascular ultrasound findings of a randomized study Am Heart J 149 2005 e1 e8
24. B. Scheller, C. Hehrlein, and W. Bocksch et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
25. F. Alfonso, M.J. Pérez-Vizcayno, and R. Hernandez et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial J Am Coll Cardiol 47 2006 2152 2160
26. D.R. Holmes Jr., P. Teirstein, and L. Satler et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial JAMA 295 2006 1264 1273
27. G.W. Stone, S.G. Ellis, and C.D. O'Shaughnessy et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial JAMA 295 2006 1253 1263
28. S.W. Park, S.W. Lee, and B.K. Koo et al. Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED study Int J Cardiol 131 2008 70 77
29. M. Unverdorben, C. Vallbracht, and B. Cremers et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
30. J. Mehilli, R.A. Byrne, K. Tiroch for the ISAR-DESIRE 2 Investigators Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study J Am Coll Cardiol 55 2010 2710 2716
31. S. Habara, K. Mitsudo, and K. Kadota et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 149 154
32. M. Wiemer, A. König, and J. Rieber et al. Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial EuroIntervention 6 2011 687 694
33. H. Rittger, J. Brachmann, and A.M. Sinha et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 2012 1377 1382
34. H.G. Song, D.W. Park, and Y.H. Kim et al. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation J Am Coll Cardiol 59 2012 1093 1100
35. B. Chevalier, R. Moulichon, and E. Teiger et al. One-year results of the CRISTAL trial, a randomized comparison of Cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents J Interv Cardiol 25 2012 586 595
36. R.A. Byrne, F.J. Neumann, and J. Mehilli et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 2013 461 467
37. S. Habara, M. Iwabuchi, and N. Inoue et al. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis Am Heart J 166 2013 527 533.e2
38. F. Alfonso, M.J. Pérez-Vizcayno, and A. Cárdenas et al. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent in-stent restenosis: the RIBS V Clinical Trial J Am Coll Cardiol 63 2014 1378 1386
39. B. Xu, R. Gao, J. Wang for the PEPCAD China ISR Trial Investigators A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial J Am Coll Cardiol Intv 7 2014 204 211
40. G. Nakazawa, F. Otsuka, and M. Nakano et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 2011 1314 1322
41. R.E. Kuntz, and D.S. Baim Defining coronary restenosis. Newer clinical and angiographic paradigms Circulation 88 1993 1310 1323
42. R. Mehran, G. Dangas, and A.S. Abizaid et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
43. E. Solinas, G. Dangas, and A.J. Kirtane et al. Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention Am J Cardiol 102 2008 311 315
44. F. Alfonso, A. Cequier, and J. Angel et al. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial Am Heart J 151 2006 681.e1 681.e9
45. F. Alfonso, M.J. Pérez-Vizcayno, and A. Cruz et al. Treatment of patients with in-stent restenosis EuroIntervention 5 Suppl D 2009 D70 D78
46. M.S. Chen, J.M. John, D.P. Chew, D.S. Lee, S.G. Ellis, and D.L. Bhatt Bare metal stent restenosis is not a benign clinical entity Am Heart J 151 2006 1260 1264
47. R.A. Hernández, C. Macaya, and A. Iñiguez et al. Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty J Am Coll Cardiol 19 1992 1402 1409
48. D.S. Pinto, G.W. Stone, and S.G. Ellis et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial J Am Coll Cardiol 48 2006 32 36
49. T. Uchida, J. Popma, and G.W. Stone et al. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions J Am Coll Cardiol Intv 3 2010 403 411
50. R. Lopez-Palop, E. Pinar, I. Lozano, D. Saura, F. Picó, and M. Valdés Utility of the fractional flow reserve in the evaluation of angiographically moderate in-stent restenosis Eur Heart J 25 2004 2040 2047
51. C.W. Nam, S.W. Rha, and B.K. Koo et al. Usefulness of coronary pressure measurement for functional evaluation of drug-eluting stent restenosis Am J Cardiol 107 2011 1783 1786
52. R.A. Byrne, M. Joner, T. Tada, and A. Kastrati Restenosis in bare metal and drug-eluting stents: distinct mechanistic insights from histopathology and optical intravascular imaging Minerva Cardioangiol 60 2012 473 489
53. T. Kimura, H. Yokoi, and Y. Nakagawa et al. Three-year follow-up after implantation of metallic coronary-artery stents N Engl J Med 334 1996 561 566
54. R.A. Byrne, R. Iijima, and J. Mehilli et al. Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer J Am Coll Cardiol Intv 2 2009 291 299
55. A.V. Finn, G. Nakazawa, F.D. Kolodgie, and R. Virmani Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing? J Am Coll Cardiol Intv 2 2009 300 302
56. K. Fujii, G.S. Mintz, and Y. Kobayashi et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis Circulation 109 2004 1085 1088
57. F. Alfonso, J. Sandoval, A. Cárdenas, M. Medina, C. Cuevas, and N. Gonzalo Optical coherence tomography: from research to clinical application Minerva Med 103 2012 441 464
58. D.J. Angiolillo, M. Sabaté, F. Alfonso, and C. Macaya "Candy wrapper" effect after drug-eluting stent implantation: déjà vu or stumbling over the same stone again? Catheter Cardiovasc Interv 61 2004 387 391
59. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, and R. Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
60. W. Wijns, P. Kolh, and N. Danchin et al. Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
61. R. Waksman, A.E. Ajani, and E. Pinnow et al. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS Circulation 106 2002 776 778
62. D. Mukherjee, J.P. Reginelli, and D.J. Moliterno et al. Unexpected mortality reduction with abciximab for in-stent restenosis J Invasive Cardiol 12 2000 540 544
63. A. Moustapha, A.R. Assali, and S. Sdringola et al. Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosis Catheter Cardiovasc Interv 56 2002 184 187
64. S. Kufner, J. Hausleiter, and G. Ndrepepa et al. Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis J Am Coll Cardiol Intv 2 2009 1142 1148
65. M. Gaudino, C. Cellini, and C. Pragliola et al. Arterial versus venous bypass grafts in patients with in-stent restenosis Circulation 112 Suppl 9 2005 I265 I269
66. C. Malle, T. Tada, and K. Steigerwald et al. Tissue characterization after drug-eluting stent implantation using optical coherence tomography Arterioscler Thromb Vasc Biol 33 2013 1376 1383
67. S.J. Kang, G.S. Mintz, and T. Akasaka et al. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation Circulation 123 2011 2954 2963
68. F. Alfonso, F. Fernandez-Viña, M. Medina, and R. Hernandez Neoatherosclerosis: the missing link between very late stent thrombosis and very late in-stent restenosis J Am Coll Cardiol 61 2013 e155
69. K. Yamaji, K. Inoue, and T. Nakahashi et al. Bare metal stent thrombosis and in-stent neoatherosclerosis Circ Cardiovasc Interv 5 2012 47 54
70. P.J. Macander, G.S. Roubin, S.K. Agrawal, A.D. Cannon, L.S. Dean, and W.A. Baxley Balloon angioplasty for treatment of in-stent restenosis: feasibility, safety, and efficacy Cathet Cardiovasc Diagn 32 1994 125 131
71. R. Mehran, G.S. Mintz, and J.J. Popma et al. Mechanisms and results of balloon angioplasty for the treatment of in-stent restenosis Am J Cardiol 78 1996 618 622
72. F. Alfonso, M.J. Pérez-Vizcayno, and R. Hernández et al. Long-term outcome and determinants of event-free survival in patients treated with balloon angioplasty for in-stent restenosis Am J Cardiol 83 1999 1268 1270
73. Y. Raja, H.C. Routledge, and S.N. Doshi A noncompliant, high pressure balloon to manage undilatable coronary lesions Catheter Cardiovasc Interv 75 2010 1067 1073
74. F. Alfonso, M.J. Pérez-Vizcayno, and M. Gómez-Recio et al. Implications of the "watermelon seeding" phenomenon during coronary interventions for in-stent restenosis Catheter Cardiovasc Interv 66 2005 521 527
75. F. Alfonso, C. Hernández, and M.J. Pérez-Vizcayno et al. Fate of stent-related side branches after coronary intervention in patients with in-stent restenosis J Am Coll Cardiol 36 2000 1.549 1.556
76. M. Adamian, A. Colombo, and C. Briguori et al. Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty J Am Coll Cardiol 38 2001 672 679
77. Y. Kobayashi, R. Mehran, and G.S. Mintz et al. Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis Am J Cardiol 92 2003 1329 1331
78. P. Fasseas, J.L. Orford, and R. Lennon et al. Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis Catheter Cardiovasc Interv 63 2004 152 157
79. M. Takano, M. Yamamoto, and D. Murakami et al. Optical coherence tomography after new scoring balloon angioplasty for in-stent restenosis and de novo coronary lesions Int J Cardiol 141 2010 e51 e53
80. G.S. Mintz, R. Hoffmann, and R. Mehran et al. In-stent restenosis: the Washington Hospital Center experience Am J Cardiol 81 1998 7E 13E
81. R. Mehran, G. Dangas, and G.S. Mintz et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty versus rotational atherectomy: comparative mechanisms and results Circulation 101 2000 2484 2489
82. P.L. Sanchez, M. Rodriguez-Alemparte, and P.J. Colon-Hernandez et al. Directional coronary atherectomy vs. rotational atherectomy for the treatment of in-stent restenosis of native coronary arteries Catheter Cardiovasc Interv 58 2003 155 161
83. Y. Kobayashi, P. Teirstein, T. Linnemeier, G. Stone, M. Leon, and J. Moses Rotational atherectomy (stentablation) in a lesion with stent underexpansion due to heavily calcified plaque Catheter Cardiovasc Interv 52 2001 208 211
84. L. Vales, J. Coppola, and T. Kwan Successful expansion of an underexpanded stent by rotational atherectomy Int J Angiol 22 2013 63 68
85. F. Alfonso, J. Sandoval, and C. Nolte Calcified in-stent restenosis: a rare cause of dilation failure requiring rotational atherectomy Circ Cardiovasc Interv 5 2012 e1 e2
86. M. Sabaté, M.A. Costa, and K. Kozuma et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy Circulation 101 2000 2467 2471
87. M.A. Costa, M. Sabaté, and W.J. van der Giessen et al. Late coronary occlusion after intracoronary brachytherapy Circulation 100 1999 789 792
88. R. Torguson, M. Sabaté, and R. Deible et al. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis Am J Cardiol 98 2006 1340 1344
89. C. Morís, F. Alfonso, and J.L. Lambert et al. Stenting for coronary dissection after balloon dilation of in-stent restenosis: stenting a previously stented site Am Heart J 131 1996 834 836
90. F. Alfonso, A. Cequier, and J. Zueco et al. Stenting the stent: initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis Am J Cardiol 85 2000 327 332
91. F. Alfonso, R. Melgares, and V. Mainar et al. Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the Restenosis Intra-stent Balloon Angioplasty Versus Elective Stenting (RIBS) randomized trial Eur Heart J 25 2004 1829 1835
92. P.A. Lemos, C.A. van Mieghem, and C.A. Arampatzis et al. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes Circulation 109 2004 2500 2502
93. A. Dibra, A. Kastrati, and F. Alfonso et al. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials J Am Coll Cardiol 49 2007 616 623
94. F. Alfonso, M.J. Pérez-Vizcayno, and R. Hernández et al. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon Angioplasty vs. Elective Sirolimus-eluting Stenting) study J Am Coll Cardiol 52 2008 1621 1627
95. A. Latib, M. Mussardo, and A. Ielasi et al. Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 155 164
96. A. Kastrati, and R. Byrne New roads, new ruts: lessons from drug-eluting stent restenosis J Am Coll Cardiol Intv 4 2011 165 167
97. F. Alfonso, M.J. Pérez-Vizcayno, and J. Dutary et al. Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]) J Am Coll Cardiol Intv 5 2012 728 737
98. F. Alfonso, J. Nuccio, C. Cuevas, A. Cárdenas, N. Gonzalo, and P. Jiménez-Quevedo Treatment of coronary in-stent restenosis with bioabsorbable vascular scaffolds J Am Coll Cardiol 63 2014 2875
99. F. Alfonso, J. García, and M.J. Pérez-Vizcayno et al. New stent implantation for recurrences after stenting for in-stent restenosis: implications of a third metal layer in human coronary arteries J Am Coll Cardiol 54 2009 1036 1038
100. R.A. Byrne, M. Joner, F. Alfonso, and A. Kastrati Drug-coated balloon therapy in coronary and peripheral artery disease Nat Rev Cardiol 11 2014 13 23
101. A. Indermuehle, R. Bahl, and A.J. Lansky et al. Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials Heart 99 2013 327 333
102. B. Scheller, Y.P. Clever, and B. Kelsch et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter J Am Coll Cardiol Intv 5 2012 323 330
103. F. Alfonso, P. Jimenez-Quevedo, N. Gonzalo, M. Medina, and C. Bañuelos Neoatherosclerosis after paclitaxel-coated balloon angioplasty for in-stent restenosis Circulation 129 2014 923 925
104. B. Cremers, S. Schmitmeier, Y.P. Clever, G. Gershony, U. Speck, and B. Scheller Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter Catheter Cardiovasc Interv 2013 Nov 21 [E-pub ahead of print]